Notice: Undefined index: HTTP_REFERER in D:\CNES\index.php on line 3
Urispas (Flavoxate Hydrochloride Tablets): Side Effects, Uses, Dosage, Interactions, Warnings

Urispas

Medical Editor: John P. Cunha, DO, FACOEP Last updated on RxList: 7/27/2023

Drug Summary

What Is Urispas?

Urispas (flavoxate HCl) is a synthetic urinary tract spasmolytic used to treat bladder symptoms such as frequent or urgent urination, increased nighttime urination, bladder pain, and incontinence (urine leakage). These bladder symptoms are often caused by overactive bladder, prostate enlargement, bladder infections, or irritation of the urethra. Urispas is not an antibiotic, and does not cure infections. Urispas is available in generic form.

What Are Side Effects of Urispas?

Urispas may cause serious side effects including:

  • hives,
  • difficulty breathing,
  • mood changes,
  • confusion,
  • eye pain, and
  • swelling of your face, lips, tongue or throat

Get medical help right away, if you have any of the symptoms listed above.

Common side effects of Urispas include:

  • nausea,
  • vomiting,
  • dry mouth,
  • headache,
  • drowsiness,
  • dizziness,
  • spinning sensation,
  • blurred vision,
  • nervousness, and
  • fever.

Tell your doctor if you have unlikely but serious side effects of Urispas including:

  • mental/mood changes (e.g., confusion), or
  • eye pain.

Seek medical care or call 911 at once if you have the following serious side effects:

  • Serious eye symptoms such as sudden vision loss, blurred vision, tunnel vision, eye pain or swelling, or seeing halos around lights;
  • Serious heart symptoms such as fast, irregular, or pounding heartbeats; fluttering in your chest; shortness of breath; and sudden dizziness, lightheadedness, or passing out;
  • Severe headache, confusion, slurred speech, arm or leg weakness, trouble walking, loss of coordination, feeling unsteady, very stiff muscles, high fever, profuse sweating, or tremors.

This document does not contain all possible side effects and others may occur. Check with your physician for additional information about side effects.

Dosage for Urispas

The dose of Urispas for adults and children over 12 years of age is one or two 100 mg tablets 3 or 4 times a day. This drug is not recommended for children under 12 years of age.

What Drugs, Substances, or Supplements Interact with Urispas?

Urispas may interact with other bladder or urinary medications such as darifenacin, oxybutynin, tolterodine, or solifenacin. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors.

Urispas During Pregnancy and Breastfeeding

During pregnancy, Urispas should be used only when prescribed. It is not known whether this drug passes into breast milk. Consult your doctor before breastfeeding.

Additional Information

Our Urispas (flavoxate HCl) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

/h4>

Description for Urispas

URISPAS® (flavoxate HC1) tablets contain flavoxate hydrochloride, a synthetic urinary tract spasmolytic.

Chemically, flavoxate hydrochloride is 2-piperidinoethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate hydrochloride. The empirical formula of flavoxate hydrochloride is C24H25NO4• HCl. The molecular weight is 427.94. The structural formula appears below.

URISPAS (flavoxate hydrochloride) Structural Formula Illustration

URISPAS® is supplied in tablets for oral administration. Each round, white, film-coated URISPAS® tablet is debossed with the product name URISPAS® and contains flavoxate hydrochloride, 100 mg. Inactive ingredients consist of calcium phosphate, hypromellose, magnesium stearate, polyethylene glycol, starch and talc.

FDA Logo

Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.